Systolic time intervals revisited: correlations with N-terminal pro-brain natriuretic peptide in a community population

被引:0
|
作者
Hao-Min Cheng
Shao-Yuan Chuang
Pai-Feng Hsu
Pesus Chou
Chen-Huan Chen
机构
[1] Taipei Veterans General Hospital,Division of Cardiology, Department of Medicine
[2] National Yang-Ming University,Community Medicine Research Center
[3] National Yang-Ming University,Cardiovascular Research Center
[4] National Yang-Ming University,Department of Social Medicine
来源
Heart and Vessels | 2005年 / 20卷
关键词
NT-proBNP; Heart failure; Systolic time interval;
D O I
暂无
中图分类号
学科分类号
摘要
The usefulness of automated measurements of the systolic time intervals in community screening deserves investigation. The systolic time intervals, including pre-ejection period (PEP), the left ventricular ejection time (LVET), and PEP/LVET were automatically and rapidly determined from signals of electrocardiography, phonocardiography, and pulse volume recording in 1087 residents aged ≥40 years in a community of homogeneous Chinese. Receiver operating characteristics analysis was performed to determine the cutoff values for PEP, ET, and PEP/LVET in predicting high N-terminal pro-brain natriuretic peptide (NT-proBNP). The prevalence of high NT-proBNP was 12.3% in men and 8.3% in women. NT-proBNP was linearly related to both PEP and PEP/LVET, while there was a U-shaped relationship between NT-proBNP and LVET. In men, the sensitivity and specificity in predicting high NT-proBNP levels were 60% and 60%, respectively, for PEP ≥ 89 ms; 60% and 62% for PEP/LVET ≥ 0.31; and 63% and 60% for LVET < 272 ms or LVET ≥ 310 ms. Various combinations of the criteria further improved either sensitivity or specificity. Women had slightly different cutoff values and performance for the various criteria of abnormal systolic time intervals and their combinations. Automated systolic time intervals appear to be useful in the screening of subjects with high NT-proBNP in a community.
引用
收藏
页码:256 / 263
页数:7
相关论文
共 50 条
  • [31] N-terminal pro-brain natriuretic peptide and abnormal brain aging The AGES-Reykjavik Study
    Sabayan, Behnam
    van Buchem, Mark A.
    de Craen, Anton J. M.
    Sigurdsson, Sigurdur
    Zhang, Qian
    Harris, Tamara B.
    Gudnason, Vilmundur
    Arai, Andrew E.
    Launer, Lenore J.
    NEUROLOGY, 2015, 85 (09) : 813 - 820
  • [32] Exercise Dependence of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Precapillary Pulmonary Hypertension
    Grachtrup, Sabine
    Bruegel, Mathias
    Pankau, Hans
    Halank, Michael
    Wirtz, Hubert
    Seyfarth, Hans-Juergen
    RESPIRATION, 2012, 84 (06) : 454 - 460
  • [33] The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients
    Hyo Jin Choi
    Young Kee Shin
    Hyun Joo Lee
    Joo Young Kee
    Dong Woo Shin
    Eun Young Lee
    Yun Jong Lee
    Eun Bong Lee
    Yeong Wook Song
    Clinical Rheumatology, 2008, 27 : 437 - 442
  • [34] Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy
    Tarnow, L
    Hildebrandt, P
    Hansen, BV
    Borch-Johnsen, K
    Parving, HH
    DIABETOLOGIA, 2005, 48 (01) : 149 - 155
  • [35] Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery
    Liu, Hua
    Wang, Chunsheng
    Liu, Lan
    Zhuang, Yamin
    Yang, Xiaomei
    Zhang, Ying
    JOURNAL OF CARDIOTHORACIC SURGERY, 2013, 8
  • [36] The Diagnostic Value of N-terminal Pro-brain Natriuretic Peptide in Differentiating Cardioembolic Ischemic Stroke
    Hajsadeghi, Shokoufeh
    Amin, Ladan Kashani
    Bakhshandeh, Hooman
    Rohani, Mohammad
    Azizian, Amir Reza
    Kerman, Scott Reza Jafarian
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (04) : 554 - 560
  • [37] The role of N-terminal pro-brain natriuretic peptide in evaluating the prognosis of patients with intracerebral hemorrhage
    Fei Li
    Qian-Xue Chen
    Shou-Gui Xiang
    Shi-Zhun Yuan
    Xi-Zhen Xu
    Journal of Neurology, 2017, 264 : 2081 - 2087
  • [38] N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?
    Allanore, Y.
    Wahbi, K.
    Borderie, D.
    Weber, S.
    Kahan, A.
    Meune, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (12) : 1885 - 1889
  • [39] N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy
    Zhang, Zeng-Lei
    Xu, Yan-Yan
    Qin, Zhen
    Lu, Yong-Zheng
    Liu, Tian-Ding
    Zhang, Li
    Shangguan, Jia-Hong
    Wang, Wei
    Tang, Jun-Nan
    Zhang, Jin-Ying
    BIOSCIENCE REPORTS, 2022, 42 (01)
  • [40] Association of N-terminal pro-brain natriuretic peptide with survival among US cancer survivors
    Cao, Chao
    Yang, Lin
    Nohria, Anju
    Mayer, Erica L.
    Partridge, Ann H.
    Ligibel, Jennifer A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (06): : 938 - 947